
A Carnegie Mellon Researcher Raises $35 Million For Clinical Intelligence
By Amy Feldman, Forbes Staff
Carnegie Mellon spinout Xlue gains the backing of Sarah Guo’s VC firm Conviction to use AI to help identify which patients are most at risk of developing cancer.
This story was published by Forbes. Read the full article on their site.
Read the full story at forbes.com(opens in a new tab)







